GAIN THERAPEUTICS INC (GANX) Institutional Ownership and Insiders Activity

GAIN THERAPEUTICS INC (GANX) is widely held by institutional investors, with 2 tracked firms reporting positions valued at approximately $3.02M based on SEC Form 13F filings for the quarter ended March 31, 2026.

Greenlight Capital is the largest disclosed holder, reporting approximately $1.92M in GANX holdings in its latest filing.

Institutional ownership among tracked investors remains highly concentrated, with Greenlight Capital representing the majority of disclosed value.